Cannabinoids in Medical Cannabis
Dr. Rana Zeine, a Medical Cannabis Expert, Unveils Groundbreaking Insights in Her Latest Publication: Cannabinoids' Impact on Cancer, Multiple Sclerosis, Epilepsy, Parkinson's & Neurodegenerative Diseases
"This book reviews the medical benefits of medicinal cannabis for cancers, neuroinflammatory, and neurodegenerative diseases. The United States government plans to reclassify medical cannabis to allow for research that would revolutionize the practice of medicine."
– Dr. Rana Zeine
About Editor
Dr.
Rana Zeine MD, PhD, MBA is adjunct faculty at Kean University and visiting professor at Chamberlain University College of Nursing, teaching Immunology, Biology of Cancer, Biological Aspects of Aging, and Microbiology. She was associate professor of Pathology at the Saint James School of Medicine. She earned her BS in Biology, Teaching Diploma and MD degrees from the American University of Beirut with elective rotations in neuropediatrics at Massachusetts General Hospital and Boston Children's Hospital, Harvard Medical. Her PhD from McGill University focused on cancer, autoimmunity and neuroimunology. She was research associate for multiple sclerosis at the University of Ottawa and Albert Einstein College of Medicine where she completed residency in pathology and fellowship in neuropathology (2004) at Montefiore Medical Center, Bronx, NY. She was research scientist for dementia at Nathan Kline Institute, and research faculty for neuroblastoma at Northwestern Univ. and the University of Chicago. Dr. Zeine earned an MBA with Distinction (2012) from Keller Graduate School of Management and is accredited in organizational culture & effectiveness from Human Synergistics International.
Dr. Brian W. Teasdale received his M.S. in Botany from the University
of South Florida in 1998 and his Ph.D. in Plant Biology at the University
of New Hampshire in 2004. After spending two years at Jacksonville
University, he moved to Kean University in 2006 where he has
remained and currently serves as both faculty and the Associate Dean
of the Dorothy & George Hennings College of Science, Mathematics,
and Technology. He specializes in molecular genetics, population
genetics, phycology, and medicinal plants. In addition to teaching a
specialized course on Cannabis he has worked as a resource in
Cannabis biology for the New Jersey Traffic Safety program
About IGI Global – Publishing Tomorrow’s Research Today
Founded in 1988 and headquartered in Hershey, Pennsylvania, USA with a subsidiary office (IGI Science and Technology, Ltd.) operating out of Beijing, China, IGI Global is a leading medium-sized independent international academic publisher of cutting-edge, high-quality, peer-reviewed scholarly reference publications in the three major academic subject areas of
Business & Management,
Scientific, Technical, & Medical (STM), and
Education. With a commitment to facilitating the discovery of pioneering scientific research, this publishing house has empowered over 200,000+ expert researchers from leading institutions globally to bring advanced research books from conceptualization to completion in an impressive 6-9 months from proposal acceptance to publication. IGI Global journal articles have a rapid turnaround, on average taking 2-4 weeks, and are then added to a significant portfolio of nearly 200 journals within IGI Global’s Open Access Journal Program. Through traditional and open access publishing workflows, this unique proprietary process makes
tomorrow’s research, which enhances and expands the body of knowledge, available to the research community
today.
Learn more about IGI Global
here.